Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

506 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis.
Ceccarelli F, D'Alfonso S, Perricone C, Carlomagno Y, Alessandri C, Croia C, Barizzone N, Montecucco C, Galeazzi M, Sebastiani GD, Minisola G, Fiocco U, Valesini G. Ceccarelli F, et al. Among authors: galeazzi m. Clin Exp Rheumatol. 2012 Nov-Dec;30(6):939-42. Epub 2012 Dec 17. Clin Exp Rheumatol. 2012. PMID: 22992305
Remission in early, aggressive rheumatoid arthritis: a multicentre prospective observational Italian study ARPA (Artrite Reumatoide Precoce Aggressiva).
Ceccarelli F, Perricone C, Trotta F, Cuomo G, Pellerito R, Bagnato G, Salaffi F, Caporali R, Cutolo M, Galeazzi M, Fiocco U, Lapadula G, Bombardieri S, Bianchi G, Gorla R, Giardina AR, Gallo G, Giardino AM, Valesini G; Arpa Study Group. Ceccarelli F, et al. Among authors: galeazzi m. Clin Exp Rheumatol. 2013 May-Jun;31(3):341-9. Epub 2013 Feb 1. Clin Exp Rheumatol. 2013. PMID: 23380023
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.
Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, Falappone PC, Ferrante A, Malesci D, Massara A, Nacci F, Secchi ME, Manganelli S, Salaffi F, Bambara ML, Bombardieri S, Cutolo M, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Grassi W, Lapadula G, Cerinic MM, Montecucco C, Trotta F, Triolo G, Valentini G, Valesini G, Ferraccioli GF; GISEA group. Mancarella L, et al. Among authors: galeazzi m. J Rheumatol. 2007 Aug;34(8):1670-3. Epub 2007 Jul 1. J Rheumatol. 2007. PMID: 17611987
Genetic aspects of the antiphospholipid syndrome: An update.
Sebastiani GD, Iuliano A, Cantarini L, Galeazzi M. Sebastiani GD, et al. Among authors: galeazzi m. Autoimmun Rev. 2016 May;15(5):433-9. doi: 10.1016/j.autrev.2016.01.005. Epub 2016 Jan 21. Autoimmun Rev. 2016. PMID: 26804759 Review.
An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab.
Scrivo R, Giardino AM, Salvarani C, Foti R, Afeltra A, Viapiana O, Giacomelli R, Salaffi F, Galeazzi M, Ramonda R, Ciccia F, Valesini G, Iannone F; Predicting MDA in PsA Study Group. Scrivo R, et al. Among authors: galeazzi m. Clin Exp Rheumatol. 2020 Jan-Feb;38(1):107-114. Epub 2019 Jul 8. Clin Exp Rheumatol. 2020. PMID: 31287400
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus.
Prevete I, Iuliano A, Cauli A, Piga M, Iannone F, Coladonato L, Bortoluzzi A, Silvagni E, Tani C, Elefante E, Doria A, Iaccarino L, Franceschini F, Fredi M, Conti F, Spinelli FR, Frediani B, Gonzales Garcìa E, Scirè CA, Zanetti A, Rozza D, Carrara G, Sebastiani GD; Early Lupus project. Prevete I, et al. Clin Exp Rheumatol. 2023 Jan;41(1):145-150. doi: 10.55563/clinexprheumatol/oo5ymg. Epub 2022 Jul 26. Clin Exp Rheumatol. 2023. PMID: 35894063 Free article.
506 results